Sundrug reports strong Q1 growth in sales and profit

Sundrug Co reported a 6.7% increase in net sales to 207,698 million yen for Q1 FY2026, with operating profit up 12.4% to 12,276 million yen and ordinary profit rising 14.1% to 12,147 million yen.

Profit attributable to owners grew 9.0% to 7,944 million yen. The company maintained its full-year consolidated financial results forecast with no revisions to dividends or earnings targets.